Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapy. JHSCI [Internet]. 2021 Sep. 16 [cited 2025 May 2];11(2):137-41. Available from: https://www.jhsci.ba/ojs/index.php/jhsci/article/view/1283